TY - JOUR
KW - Chromoblastomycosis
KW - Antifungais
KW - Diagnostic medicine
KW - Fungi
KW - fungal diseases
KW - Neglected tropical diseases (NTDs)
KW - Global health
AU - Smith DJ
AU - Queiroz-Telles F
AU - Rabenja FR
AU - Hay R
AU - Bonifaz A
AU - Grijsen ML
AU - Blaizot R
AU - Messina F
AU - Song Y
AU - Lockhart SR
AU - Jordan A
AU - Cavanaugh AM
AU - Litvintseva AP
AU - Chiller T
AU - Schito M
AU - de Hoog S
AU - Vicente VA
AU - Cornet M
AU - Dagne DA
AU - Ramarozatovo LS
AU - de Azevedo CDMPES
AU - Santos DWCL
AU - Bongomin F
AB - <jats:p>Chromoblastomycosis, an implantation mycosis, is a neglected tropical disease that causes decreased quality of life, stigma, and disability. The global burden of disease is unknown and data on disease epidemiology and outcomes are severely limited by a lack of access to needed diagnostic tools and therapeutics. The World Health Organization outlined targets for chromoblastomycosis in the Road Map for Neglected Tropical Diseases 2021–2030, but little progress has been made in initiating and implementing an effective control program globally. This lack of guiding policy and progress led to the recent formation of a Global Chromoblastomycosis Working Group which has developed a global chromoblastomycosis strategy. We describe this strategy, which outlines specific steps needed to improve technical progress, strategy and service delivery, and enablers. Clinicians, researchers, public and government officials, patients, and policy makers can align their time, expertise, and resources to improve the lives of communities affected by chromoblastomycosis through this strategy.</jats:p>
BT - PLOS Neglected Tropical Diseases
DO - 10.1371/journal.pntd.0012562
IS - 10
LA - ENG
M3 - Article
N2 - <jats:p>Chromoblastomycosis, an implantation mycosis, is a neglected tropical disease that causes decreased quality of life, stigma, and disability. The global burden of disease is unknown and data on disease epidemiology and outcomes are severely limited by a lack of access to needed diagnostic tools and therapeutics. The World Health Organization outlined targets for chromoblastomycosis in the Road Map for Neglected Tropical Diseases 2021–2030, but little progress has been made in initiating and implementing an effective control program globally. This lack of guiding policy and progress led to the recent formation of a Global Chromoblastomycosis Working Group which has developed a global chromoblastomycosis strategy. We describe this strategy, which outlines specific steps needed to improve technical progress, strategy and service delivery, and enablers. Clinicians, researchers, public and government officials, patients, and policy makers can align their time, expertise, and resources to improve the lives of communities affected by chromoblastomycosis through this strategy.</jats:p>
PB - Public Library of Science (PLoS)
PY - 2024
SP - 1
EP - 12
T2 - PLOS Neglected Tropical Diseases
TI - A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group
UR - https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0012562&type=printable
VL - 18
SN - 1935-2735
ER -